Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease

Fig. 3

Kaplan-Meier survival curves of renal endpoint in patients with UMCP-1 (ng/mgCr), UEGF (ng/mgCr), UEGF/MCP-1 (ng/ng) and UACR (mg/gCr) above and below the optimal receiver operating characteristics cutoff level of each tubular biomarkers. a) UMCP-1Ā ā‰„Ā 2.08Ā ng/mgCr, b) UEGF ā‰¤29.9Ā ng/mgCr, c) UEGF/MCP-1ā€‰ā‰¤ā€‰9.16Ā ng/ng, d) UACR ā‰„330.96Ā mg/gCr showed a significantly faster progression to endpoint (pā€‰<ā€‰0.001, log-rank test). Abbreviations: UACR urine albumin creatinine ratio, UEGF urine epidermal growth factor creatinine ratio, UEGF/MCP-1 urine epidermal growth factor and monocyte chemoattractant protein-1 ratio, UMCP-1 urine monocyte chemoattractant protein-1 creatinine ratio

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us